ARK Genomic Revolution ETF
ARKG
ARKG
293 hedge funds and large institutions have $653M invested in ARK Genomic Revolution ETF in 2023 Q1 according to their latest regulatory filings, with 28 funds opening new positions, 79 increasing their positions, 95 reducing their positions, and 46 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
293
Holders Change
-26
Holders Change %
-8.15%
% of All Funds
4.69%
Holding in Top 10
–
Holding in Top 10 Change
-2
Holding in Top 10 Change %
-100%
% of All Funds
–
New
28
Increased
79
Reduced
95
Closed
46
Calls
$51.8M
Puts
$97.2M
Net Calls
-$45.5M
Net Calls Change
-$45.6M
Top Buyers
| 1 |
BNP Paribas Financial Markets
Paris,
France
|
+$38.5M |
| 2 |
Citigroup
New York
|
+$32.9M |
| 3 |
Bank of America
Charlotte,
North Carolina
|
+$27.7M |
| 4 |
Morgan Stanley
New York
|
+$16.9M |
| 5 |
Goldman Sachs
New York
|
+$7.18M |
Top Sellers
| 1 |
AWA
Arete Wealth Advisors
Chicago,
Illinois
|
-$227M |
| 2 |
Chevy Chase Trust
Bethesda,
Maryland
|
-$3.45M |
| 3 |
Jane Street
New York
|
-$3.16M |
| 4 |
National Bank of Canada
Montreal,
Quebec, Canada
|
-$2.6M |
| 5 |
TRCT
Tower Research Capital (TRC)
New York
|
-$2.46M |
